Vor is a biopharmaceutical company that believes science can change the course of disease.
Join Vor in tackling autoimmune disease at its root by advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor. As a Medical Director, you'll drive the development and execution of medical affairs strategy and tactics for Telitacicept in pSD, shaping the global launch strategy and ensuring market readiness.
Vor is a biopharmaceutical company that believes science can change the course of disease.
Vor Bio